Back to Browse Journals » International Journal of Nanomedicine » Volume 2 » Issue 4

Nano-liposomal dry powder inhaler of tacrolimus: Preparation, characterization, and pulmonary pharmacokinetics

Authors Mahavir Chougule, Bijay Padhi, Ambikanandan Misra

Published 15 January 2008 Volume 2007:2(4) Pages 675—688

Mahavir Chougule, Bijay Padhi, Ambikanandan Misra

TIFAC-CORE in NDDS, Pharmacy Department, Faculty of Technology and Engineering, The Maharaja Sayajirao University of Baroda, Kalabhavan, Vadodara, India

Abstract: The studies were undertaken to evaluate feasibility of pulmonary delivery of liposomaly encapsulated tacrolimus dry powder inhaler for prolonged drug retention in lungs as rescue therapy to prevent refractory rejection of lungs after transplantation. Tacrolimus encapsulated liposomes were prepared by thin film evaporation technique and liposomal dispersion was passed through high pressure homogenizer. Tacrolimus nano-liposomes (NLs) were separated by centrifugation and characterized. NLs were dispersed in phosphate buffer saline (PBS) pH 7.4 containing different additives like lactose, sucrose, and trehalose, and L-leucine as antiadherent. The dispersion was spray dried and spray dried powders were characterized. In vitro and in vivo pulmonary deposition was performed using Andersen Cascade Impactor and intratracheal instillation in rats respectively. NLs were found to have average size of 140 nm, 96% ± 1.5% drug entrapment, and zeta potential of 1.107 mV. Trehalose based formulation was found to have low density, good flowability, particle size of 9.46 ± 0.8 µm, maximum fine particle fraction (FPF) of 71.1 ± 2.5%, mean mass aerodynamic diameter (MMAD) 2.2 ± 0.1 µm, and geometric standard deviation (GSD) 1.7 ± 0.2. Developed formulations were found to have in vitro prolonged drug release up to 18 hours, following Higuchi’s Controlled Release model. In vivo studies revealed maximal residence of tacrolimus within lungs of 24 hours, suggesting slow clearance from the lungs. The investigation provides a practical approach for direct delivery of tacrolimus encapsulated in NLs for controlled and prolonged retention at the site of action. It may play a promising role as rescue therapy in reducing the risk of acute rejection and chronic rejection.

Keywords: lung transplant rejection, tacrolimus, nano-liposomes, spray drying, dry powder inhaler


Download Article [PDF] 

Readers of this article also read:

Electrospun gelatin/polycaprolactone nanofibrous membranes combined with a coculture of bone marrow stromal cells and chondrocytes for cartilage engineering

He X, Feng B, Huang C, Wang H, Ge Y, Hu R, Yin M, Xu Z, Wang W, Fu W, Zheng J

International Journal of Nanomedicine 2015, 10:2089-2099

Published Date: 17 March 2015

Neurosyphilis with psychotic symptoms and Parkinsonism in a young girl

Yin L, Zou S, Huang Y

Neuropsychiatric Disease and Treatment 2015, 11:375-377

Published Date: 16 February 2015

Perioperative hyperglycemia is associated with postoperative neurocognitive disorders after cardiac surgery

Zhang X, Yan X, Gorman J, Hoffman SN, Zhang L, Boscarino JA

Neuropsychiatric Disease and Treatment 2014, 10:361-370

Published Date: 19 February 2014

Supramolecular nanoparticles generated by the self-assembly of polyrotaxanes for antitumor drug delivery

Liu R, Lai YS, He B, Li Y, Wang G, Chang S, Gu Z

International Journal of Nanomedicine 2012, 7:5249-5258

Published Date: 5 October 2012

Major risk factors for the appearance of white-matter lesions on MRI in hypertensive patients with controlled blood pressure

Takami T, Yamano S, Okada S, Sakuma M, Morimoto T, Hashimoto H, Somekawa S, Saito Y

Vascular Health and Risk Management 2012, 8:169-176

Published Date: 14 March 2012

Biocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignancies

Weiwei Wu, Baoan Chen, Jian Cheng, et al

International Journal of Nanomedicine 2010, 5:1079-1084

Published Date: 2 December 2010

Luteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomes

Yingna He, Linhua Zhang, Cunxian Song

International Journal of Nanomedicine 2010, 5:697-705

Published Date: 20 September 2010

Validation of reported physical activity for cholesterol control using two different physical activity instruments

Amy Z Fan, Sandra A Ham, Shravani Reddy Muppidi, et al

Vascular Health and Risk Management 2009, 5:649-661

Published Date: 6 August 2009

Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy

Vishal Gupta, Abraham Aseh, Carmen N Ríos, Bharat B Aggarwal, et al.

International Journal of Nanomedicine 2009, 4:115-122

Published Date: 13 May 2009

Quantitative determination of glycosaminoglycans in tears of diabetic patients

Marilita M Moschos, Alexandros A Rouvas, Spyridon Papadimitriou, Athanasios Kotsolis, Nikolaos Sitaras, Michael Apostolopoulos

Clinical Ophthalmology 2008, 2:581-584

Published Date: 12 September 2008